SUBSCRIBERS
Europe follows FDA to get nod for early stage Alzheimer's therapies
Published Thu, Mar 1, 2018 · 09:50 PM
London
EUROPEAN regulators are following in the footsteps of the US Food and Drug Administration (FDA) with plans to help pharmaceutical companies win approval for novel Alzheimer's drugs that treat the earliest stages of the memory-robbing disease.
The European Medicines Agency said on Wednesday that its new guidance would encourage the testing of new medicines even before symptoms appeared, as well as the potential use of biomark…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Swiss watch exports plunge as China and Hong Kong demand dries up
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Billionaires selling cheap stuff get richer from inflation pain
Amazon to push cashierless shopping tech into more third-party stores, while backing off itself
Japan’s Uniqlo opens Rome store as part of European expansion
Abbott beats quarterly profit estimates on strong medical device sales